CD4 and myeloid sarcoma: Earlier research has demonstrated that immune dysregulation in MS primarily stems from myelin-specific autoreactive CD4+ T cells and is strongly linked to immune dysfunction, temporary activation of immune cells, and an imbalance in immune cell subpopulation ratios [2,3].